These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21850077)

  • 41. Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat.
    Proj Inf Perspect; 2008 Dec; (47):8. PubMed ID: 19227559
    [No Abstract]   [Full Text] [Related]  

  • 42. Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis.
    Expert Rev Clin Immunol; 2010 Mar; 6(2):186. PubMed ID: 20402380
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tenofovir DF expanded access. Criteria for U.S. program.
    AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 46. Trends in unsafe sex and influence of viral load among patients followed since primary HIV infection, 2000-2009.
    Seng R; Rolland M; Beck-Wirth G; Souala F; Deveau C; Delfraissy JF; Goujard C; Meyer L
    AIDS; 2011 Apr; 25(7):977-88. PubMed ID: 21358375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unsafe sexual behaviors among HIV-positive men in Kathmandu Valley, Nepal.
    Poudel KC; Nakahara S; Poudel-Tandukar K; Yasuoka J; Jimba M
    AIDS Behav; 2009 Dec; 13(6):1143-50. PubMed ID: 18770024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA approves two combo brand-name AIDS drugs.
    Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
    [No Abstract]   [Full Text] [Related]  

  • 49. PrEP trial in women halted due to doubts that it could show efficacy.
    McEnery R
    IAVI Rep; 2011; 15(2):21. PubMed ID: 21608329
    [No Abstract]   [Full Text] [Related]  

  • 50. An equal right to protection.
    Diallo DD; Forbes A
    Posit Aware; 2013; 25(5):12-4. PubMed ID: 25358201
    [No Abstract]   [Full Text] [Related]  

  • 51. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
    Curran JW; Crosby RA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S163-6. PubMed ID: 23253761
    [No Abstract]   [Full Text] [Related]  

  • 52. Pre-exposure prophylaxis for HIV: can it be implemented in the real world?
    Katz MH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S161-2. PubMed ID: 23253760
    [No Abstract]   [Full Text] [Related]  

  • 53. From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
    Warren MJ; Bass ES
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S167-70. PubMed ID: 23253762
    [No Abstract]   [Full Text] [Related]  

  • 54. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
    Horberg M; Raymond B
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752
    [No Abstract]   [Full Text] [Related]  

  • 55. BMS issues PK notice regarding ATV + TDF.
    IAPAC Mon; 2003 Sep; 9(9):203. PubMed ID: 14672069
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
    Cohen J
    Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
    [No Abstract]   [Full Text] [Related]  

  • 57. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm?
    Richens J; Edwards SG; Sadiq ST
    Sex Transm Infect; 2005 Jun; 81(3):190-1; discussion 191-2. PubMed ID: 15923282
    [No Abstract]   [Full Text] [Related]  

  • 58. Gender attitudes, sexual violence, and HIV/AIDS risks among men and women in Cape Town, South Africa.
    Kalichman SC; Simbayi LC; Kaufman M; Cain D; Cherry C; Jooste S; Mathiti V
    J Sex Res; 2005 Nov; 42(4):299-305. PubMed ID: 19827234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emtriva gets approval.
    AIDS Patient Care STDS; 2003 Sep; 17(9):484. PubMed ID: 14596254
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.